Figure 1
Figure 1. A truncated active SphK2 (t-SphK2) is released into the supernatant of apoptotic Jurkat cells. (A-B) Jurkat cells remained as controls or were treated with Sts as described in “Induction and detection of apoptosis.” (A) Western analysis of SphK2 in subcellular fractions (nuclear [Nuc], membrane [Mem], cytosolic [Cyt]) or the cell supernatant (Sup). The histogram shows quantification of Western data as means ± SEM from 3 independent experiments. (B) SphK2 activity in Jurkat cell lysates (■) and cell supernatants (□). Data are means ± SEM from 4 independent experiments. *P < .05 compared with unstimulated controls. (C) Western analysis of SphK2 expression in whole-cell lysate (L) and supernatant (S) from Jurkat and SphK2-deficient Jurkat cells that were untreated or treated with Sts. (D) Blots show expression of SphK2 in cytosol and supernatants of control or UV-irradiated (10 mJ/cm2) Jurkat cells.

A truncated active SphK2 (t-SphK2) is released into the supernatant of apoptotic Jurkat cells. (A-B) Jurkat cells remained as controls or were treated with Sts as described in “Induction and detection of apoptosis.” (A) Western analysis of SphK2 in subcellular fractions (nuclear [Nuc], membrane [Mem], cytosolic [Cyt]) or the cell supernatant (Sup). The histogram shows quantification of Western data as means ± SEM from 3 independent experiments. (B) SphK2 activity in Jurkat cell lysates (■) and cell supernatants (□). Data are means ± SEM from 4 independent experiments. *P < .05 compared with unstimulated controls. (C) Western analysis of SphK2 expression in whole-cell lysate (L) and supernatant (S) from Jurkat and SphK2-deficient Jurkat cells that were untreated or treated with Sts. (D) Blots show expression of SphK2 in cytosol and supernatants of control or UV-irradiated (10 mJ/cm2) Jurkat cells.

Close Modal

or Create an Account

Close Modal
Close Modal